Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers
Ann Rheum Dis. 2023 May;82(5):e114.
doi: 10.1136/annrheumdis-2021-220058.
Epub 2021 Feb 18.
1 Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK [email protected].
2 National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), University College London Hospitals (UCLH) NHS Foundation Trust, London, UK.
3 Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.
4 Epidemiology and Health Care Research, German Rheumatism Research Center (DRFZ Berlin), Berlin, Germany.
5 Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France.
6 Department of Rheumatology, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.
7 Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
8 Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Manchester, UK.
9 National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK.
10 Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), European Alliance of Associations for Rheumatology (EULAR), Kilchberg, Switzerland.
11 Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
12 Instituto de Salud Musculoesquelética, Madrid, Spain.
13 Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
14 Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Brisbane, Queensland, Australia.